- PMLiVE

bluebird bio maintains its focus on gene therapy opportunities during structural changes

The company plans to reduce its workforce amid efforts to reduce its operating costs

- PMLiVE

2022 PM Society Awards

The 36th annual awards was held at the Grosvenor House Hotel in London

- PMLiVE

Sanofi unveils new corporate brand and logo

Sanofi Pasteur and Sanofi Genzyme will unite under the new brand image

- PMLiVE

Pfizer and BioNTech start clinical trial for Omicron-based COVID-19 vaccine

The clinical trial involves adults aged 18 to 55 who received an Omicron-based vaccine candidate as part of a two-dose primary series, as well as a booster

- PMLiVE

Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events

With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay

- PMLiVE

Almirall and IRB Barcelona announce new research collaboration

The two companies will work together to discover new therapies for chronic skin diseases

- PMLiVE

Discovering the unique power of DOLs – are you harnessing the power of pharma’s new educators?

By Akarsh Sakalaspur

What if pharma engaged its customers like Netflix or Amazon?

By Lorraine Walters

- PMLiVE

Omnichannel marketing – more than a buzzword

By Dimitri Challouma and Dominic Cleall

- PMLiVE

Not another thought leadership article… sorting the wheat from the chaff

By Rob Barlow

- PMLiVE

Boehringer Ingelheim, Lifebit to use AI to detect infectious disease outbreaks

Partnership will utilise real-world data for the early reporting of global outbreaks

- PMLiVE

The need for automation in healthcare

With wide applicability and the many time and cost savings they can bring, robots have been steadily integrated into healthcare over the last decade

- PMLiVE

Health leaders welcome EDPB’s opinion on adequacy of UK’s data protection standards

Opinion ‘paves way’ for sharing of health data between EU and the UK

- PMLiVE

Italy accelerates the path towards digital therapeutics implementation

PME talks to Roberto Ascione, Gualberto Gussoni and Giuseppe Recchia about the advancement of digital therapeutics in Italy

- PMLiVE

Researchers use AI to identify drugs that could be repurposed for Alzheimer’s

Eli Lilly's JAK inhibitor Olumiant identified as a potential treatment for repurposing